Drug Profile
Influenza virus vaccine - Chiron Vaccines
Latest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Chiron Vaccines
- Class Influenza virus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Influenza virus infections
Most Recent Events
- 03 Jun 2004 Discontinued - Phase-I for Influenza virus infections in United Kingdom (Intradermal)
- 29 Sep 2003 Data presented at the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC-2003) have been added to the adverse reactions and immunogenicity sections ,
- 26 Aug 2003 PowderJect Pharmaceuticals has been acquired by Chiron Corporation